Abstract:Background: Copy number variants platforms, as critical supports for genetic diagnosis, have been well implemented in prenatal diagnosis. However, numerous severe conditions with underlying single-gene defects are not included in current invasive prenatal screening. To bridge this gap, an expanded chromosomal microarray analysis was developed, employing a meticulous designed single nucleotide polymorphism chip. This chip incorporated additional probes to augment its efficacy in screening for spinal muscular atrophy and diagnosing monogenic disorders. Objective(s): This study aimed to evaluate the accuracy, efficacy, and incremental yield of expanded chromosomal microarray, compared with karyotype analysis and low-depth genome sequencing for routine prenatal diagnosis. Study Design: In this prospective study, total of 512 fetuses were included in this study. In this study three distinct diagnostic techniques-karyotype analysis, low-depth genome sequencing, and expanded chromosomal microarray-were processed to evaluate each sample. Aneuploidies and multigene copy number variations were detected and analyzed in a blinded fashion. SMN1 exonic copy number variations were confirmed by multiplex ligation-dependent probe amplification and single nucleotide variations were confirmed by sanger sequencing. Results: Overall, expanded chromosomal microarray identified genetic abnormalities in 91 out of 512 cases (17.6%). The encountered rate was significantly higher than the rates observed with low-depth genome sequencing (66 out of 512 cases, 12.9%) and conventional chromosome karyotyping (42 out of 512 cases, 8.2%). Expanded chromosomal microarray not only detected all these non-mosaic aneuploidies and copy number variations in 62(12.1%) diagnosed cases identified by low-depth genome sequencing (low-depth genome sequencing), but also detected 9 cases with regions of homozygosity, 10(2.0%) cases with exonic deletions (SMN1 and DMD), and 13(2.5%) cases with single nucleotide variations. Conclusions: Compared with low-depth GS, expanded chromosomal microarray increased the additional detection rate by 4.7% (24/512). Compared with traditional chromosomal microarray, expanded chromosomal microarray increased the additional detection rate by 3.9% (20/512) in 512 fetuses. Although the expanded chromosomal microarray (ECMA) has limited accuracy for detecting single nucleotide variations, its screening capacity is significantly enhanced when complemented with Sanger sequencing validation. Using expanded chromosomal microarray, we detected not only copy number variations, but also exonic deletions, regions of homozygosity with high accuracy in an acceptable turnaround time (2-3 weeks). Our results suggest that expanded chromosomal microarray has the potential to be a promising prenatal diagnostic tool with incremental yield of screening exonic copy number variations in SMN1.

Diagnostic yield of the chromosomal microarray analysis in turkish patients with unexplained development delay/ıntellectual disability(ID), autism spectrum disorders and/or multiple congenital anomalies and new clinical findings

Chromosomal Microarray Analysis in Fetuses with Congenital Anomalies of the Kidney and Urinary Tract: A Prospective Cohort Study and Meta‐analysis

[Application of Single Nucleotide Polymorphism Microarray in Clinical Diagnosis of Intellectual Disability or Retardation].

Investigation of chromosomal anomalies and copy number variations in children diagnosed with autism spectrum disorder by array CGH method

Prenatal Diagnosis of Microdeletions or Microduplications in the Proximal, Central, and Distal Regions of Chromosome 22q11.2: Ultrasound Findings and Pregnancy Outcome.

[Evaluation of Detection and Analysis of Chromosome 22q11.2 Microdeletion by Multiple Ligation-Dependent Probe Amplification Assay].

Clinical genetic testing for patients with autism spectrum disorders.

[The Diagnostic Value of Chromosome Microarray Analysis Technique in the Genetic Causes of Children with Intellectual Disability or Global Developmental Delay].

Chromosomal Microarray Analysis in Developmental Delay and Intellectual Disability with Comorbid Conditions

Chromosomal microarray testing yield in 829 cases of microcephaly: a clinical characteristics-based analysis for prenatal and postnatal cases

Clinically significant findings in a decade‐long retrospective study of prenatal chromosomal microarray testing

Chromosomal Aberrations in Pediatric Patients with Moderate/Severe Developmental Delay/Intellectual Disability with Abundant Phenotypic Heterogeneities: A Single-center Study

The diagnostic yield of genetic and metabolic investigations in syndromic and nonsyndromic patients with autism spectrum disorder, global developmental delay, or intellectual disability from a dedicated neurodevelopmental disorders genetics clinic

Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: a multicenter experience of 1499 clinical cases.

Karyotypes analyses in 632 autism spectrum disorder trios

The Evaluation of Invasive Prenatal Diagnostic Tests in North Cyprus: A Retrospective Study

Expanded chromosomal microarray comprising screening for spinal muscular atrophy and monogenic diseases

Clinical Targeted Panel Sequencing Analysis in Clinical Evaluation of Children with Autism Spectrum Disorder in China

The Diagnostic Yield of Chromosomal Microarray Analysis in Third-Trimester Fetal Abnormalities

Microduplication and Microdeletion Syndromes Diagnosed Prenatally Using Single Nucleotide Polymorphism Array

Oligonucleotide Microarrays for Clinical Diagnosis of Copy Number Variation